Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment.

Abstract

The patients with PD under L-dopa treatment have increased aortic stiffness and impaired diastolic function compared to healthy individuals. Elevated serum homocysteine levels may be a possible pathophysiological mechanism.